메뉴 건너뛰기




Volumn 27, Issue 2, 2013, Pages 107-111

The gene therapy revolution in ophthalmology

Author keywords

Age related macular degeneration (AMD); CD59; Gene therapy; Leber's Congenital Amaurosis (LCA); Primary open angle glaucoma (POAG); Retinitis pigmentosa; Stargardt's ophthalmology; Vector

Indexed keywords

CD59 ANTIGEN; NANOPARTICLE; PARVOVIRUS VECTOR;

EID: 84878628257     PISSN: 13194534     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjopt.2013.02.001     Document Type: Review
Times cited : (26)

References (25)
  • 2
    • 84878664789 scopus 로고    scopus 로고
    • MacLaren, Robert. Gene therapy. Nuffield Laboratory of Ophthalmology. [21.07.12].
    • MacLaren, Robert. Gene therapy. Nuffield Laboratory of Ophthalmology. [21.07.12]. http://www.eye.ox.ac.uk.
  • 3
    • 84878663388 scopus 로고    scopus 로고
    • Institute, National Cancer. Gene therapy for cancer: questions and answers. [25.07.12].
    • Institute, National Cancer. Gene therapy for cancer: questions and answers. [25.07.12]. http://www.cancer.gov.
  • 4
    • 84878628444 scopus 로고    scopus 로고
    • Mandal, Ananya. Retinitis pigmentosa genetics. News Medical. [21.07.12].
    • Mandal, Ananya. Retinitis pigmentosa genetics. News Medical. [21.07.12]. http://www.news-medical.net.
  • 6
    • 84878664202 scopus 로고    scopus 로고
    • Retinitis pigmentosa news and research. News medical. [12.07.12].
    • Retinitis pigmentosa news and research. News medical. [12.07.12]. http://www.news-medical.net.
  • 9
    • 84878633219 scopus 로고    scopus 로고
    • What is gene therapy? News medical. [15.07.12].
    • What is gene therapy? News medical. [15.07.12]. http://www.news-medical.net.
  • 10
    • 84878633238 scopus 로고    scopus 로고
    • Clinical features of autosomal dominant retinitis pigmentosa associated
    • Chen Haoyu, Chen Yali, Horn Rachael, Yang Zhenglin, Wang Changguan, et al. Clinical features of autosomal dominant retinitis pigmentosa associated. Ann Acad Med 2006, 35(6):412-415.
    • (2006) Ann Acad Med , vol.35 , Issue.6 , pp. 412-415
    • Chen, H.1    Chen, Y.2    Horn, R.3    Yang, Z.4    Wang, C.5
  • 11
    • 84878665763 scopus 로고    scopus 로고
    • Canine study puts gene therapy for X-linked retinitis pigmentosa in sight. National Eye Institute. [28.06.12].
    • Hays, Dustin C. Canine study puts gene therapy for X-linked retinitis pigmentosa in sight. National Eye Institute. [28.06.12]. http://www.nei.nih.gov.
    • Hays, D.C.1
  • 12
    • 84878655317 scopus 로고    scopus 로고
    • Gene therapy first for poor sight. Stargardt's Australia. [26.06.12].
    • Ghosh, Pallab. Gene therapy first for poor sight. Stargardt's Australia. [26.06.12]. http://www.stargardts-au.org.
    • Ghosh, P.1
  • 13
    • 66149105139 scopus 로고    scopus 로고
    • AAV-mediated gene therapy for retinal disorders in large animal models
    • Rolling Fabienne, Moullier Philippe, Lhériteau Elsa, Stieger Knut AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J. 2009, 50(2):206-224.
    • (2009) ILAR J. , vol.50 , Issue.2 , pp. 206-224
    • Rolling, F.1    Moullier, P.2    Lhériteau, E.3    Stieger, K.4
  • 14
    • 77649242176 scopus 로고    scopus 로고
    • Gene therapy for Leber's Congenital Amaurosis is safe and effective through 1.5 years after vector administration
    • Simonelli F., Maguire A.M., Testa F., Pierce E.A., Mingozzi F., Bennicelli J.L. Gene therapy for Leber's Congenital Amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 2010, 18(3):643-650.
    • (2010) Mol Ther , vol.18 , Issue.3 , pp. 643-650
    • Simonelli, F.1    Maguire, A.M.2    Testa, F.3    Pierce, E.A.4    Mingozzi, F.5    Bennicelli, J.L.6
  • 17
    • 65449139573 scopus 로고    scopus 로고
    • RPE65: role in the visual cycle, human retinal disease, and gene therapy
    • Cai X., Conley S.M., Naash M.I. RPE65: role in the visual cycle, human retinal disease, and gene therapy. Ophthalmic Genet 2009, 30(2):57.
    • (2009) Ophthalmic Genet , vol.30 , Issue.2 , pp. 57
    • Cai, X.1    Conley, S.M.2    Naash, M.I.3
  • 19
    • 84878666090 scopus 로고    scopus 로고
    • Stargardt disease. MD support. [28.07.12].
    • Hammer R., Stargardt disease. MD support. [28.07.12]. http://www.mdsupport.org.
    • Hammer, R.1
  • 20
    • 84878664610 scopus 로고    scopus 로고
    • Nonviral DNA nanoparticles for ocular gene therapy to treat Stargardt's disease. SciBX 5(34); doi:10.1038/scibx.2012.911. Aug. 30
    • Nonviral DNA nanoparticles for ocular gene therapy to treat Stargardt's disease. SciBX 5(34); doi:10.1038/scibx.2012.911. Aug. 30 2012.
    • (2012)
  • 21
    • 84878655217 scopus 로고    scopus 로고
    • Naash, Muna. Nanoparticle-based gene therapy preserves vision in lab study for Stargardt disease. Foundation Fighting Blindness. Web: [22.07.12].
    • Naash, Muna. Nanoparticle-based gene therapy preserves vision in lab study for Stargardt disease. Foundation Fighting Blindness. Web: [22.07.12]. http://www.blindness.org.
  • 22
    • 57449098228 scopus 로고    scopus 로고
    • Magnetic nanoparticles for gene and drug delivery
    • Dobson Jon, Yiu Humphrey H.P., McBain Stuart C. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 2008, 3(2):169-180.
    • (2008) Int J Nanomedicine , vol.3 , Issue.2 , pp. 169-180
    • Dobson, J.1    Yiu, H.H.P.2    McBain, S.C.3
  • 23
    • 84878649169 scopus 로고    scopus 로고
    • Northwest science and technology. Gene therapy treats red-green colorblindness in adult monkeys
    • Berezow A.B. Northwest science and technology. Gene therapy treats red-green colorblindness in adult monkeys. Spring 2010.
    • (2010) Spring
    • Berezow, A.B.1
  • 25
    • 74849104278 scopus 로고    scopus 로고
    • RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma
    • Li M., Xu J., Chen X., Sun X. RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma. Diagn Pathol 2009, 4(46):4-46.
    • (2009) Diagn Pathol , vol.4 , Issue.46 , pp. 4-46
    • Li, M.1    Xu, J.2    Chen, X.3    Sun, X.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.